Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Other Non-Current Assets of $360000.0 in Q4 2025, down 23.73% quarter-over-quarter from $472000.0 in Q3 2025, and down 6.01% on a YoY basis from $383000.0 in Q4 2024.
Biofrontera (BFRI) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Biofrontera's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 6.01% year-over-year to $360000.0; the TTM figure through Dec 2025 stood at $360000.0 (down 6.01% YoY), while the FY2025 annual figure was $360000.0, down 6.01% from the prior year.
- Other Non-Current Assets was $360000.0 for Q4 2025 at Biofrontera, down from $472000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q3 2021 to a low of $85000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $418411.8 across 5 years, with a median of $383000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 93.81% in 2022, then surged 478.82% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $268000.0 in 2021, then gained by 19.4% to $320000.0 in 2022, then soared by 50.62% to $482000.0 in 2023, then fell by 20.54% to $383000.0 in 2024, then fell by 6.01% to $360000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $360000.0 (Q4 2025), $472000.0 (Q3 2025), and $535000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 360,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 360,000.00 |
| Sep 30, 2025 | 472,000.00 |
| Jun 30, 2025 | 535,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 328,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 492,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 268,000.00 |
| Sep 30, 2021 | 1.37 Mn |
| Dec 31, 2020 | 121,000.00 |